An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate

Williams, L. J., Mukherjee, D., Fisher, M. et al. (4 more authors) (2014) An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate. British Journal of Pharmacology, 171 (21). pp. 4902-4913. ISSN 0007-1188

Abstract

Metadata

Authors/Creators:
  • Williams, L. J.
  • Mukherjee, D.
  • Fisher, M.
  • Reyes-Aldasoro, C. C.
  • Akerman, S.
  • Kanthou, C.
  • Tozer, G. M.
Copyright, Publisher and Additional Information: © 2014 The British Pharmacological Society. Reproduced in accordance with the publisher's self-archiving policy.
Dates:
  • Published: November 2014
  • Published (online): 24 October 2014
  • Accepted: 2 June 2014
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 23 Nov 2016 09:51
Last Modified: 23 Nov 2016 09:51
Published Version: http://dx.doi.org/10.1111/bph.12817
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1111/bph.12817
Related URLs:

Share / Export

Statistics